Mitolactol is an alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs. Mitolactol is able to cross bloodbrain barrier, consequently could control certain brain tumors. References: Jeney A, Kralovánszky J, Lapis K. [Anticancer drug research in Hungary, 1950-2000]. Magy Onkol. 2017 Dec 18;61(4):375-382. Epub 2017 Nov 30. Hungarian. PubMed PMID: 29257158.

纯度：≥98%

CAS：10318-26-0